Ruben J. Cauchi, Professor of Neurogenetics within the Department of Physiology & Biochemistry at the Faculty of Medicine & Surgery Cauchi described ALS (amyotrophic lateral sclerosis) as follows: ...
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Friday. The firm set a “sell” rating on the biopharmaceutical ...
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...